Warmuth Markus Insider Trades

Insider Trading History

Track insider trading activity for Warmuth Markus. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $10.5M 595,006 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$106k 5,466 shares
$19.44
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $10.6M 600,004 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$103k 5,467 shares
$18.92
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $10.7M 605,471 shares
Last Trade
Apr 14, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$141k 8,000 shares
$17.64
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $10.8M 613,471 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$98k 5,466 shares
$17.92
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $10.9M 620,696 shares
Last Trade
Jan 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$128k 5,466 shares
$23.49
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $11M 624,403 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$154k 10,135 shares
$15.17
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $11.2M 634,538 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.59M 496,000 shares
$15.31
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $10.1M 575,000 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.09M 575,000 shares
$7.11
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $6.09M 346,000 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.98M 346,000 shares
$5.71
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $8.3M 472,000 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.67M 472,000 shares
$7.78
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $5.55M 315,600 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.23M 315,600 shares
$13.41
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
See Remarks
Holding Value $7.33M 416,538 shares
Last Trade
Jun 23, 2021 Sale
No data
No data
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
See Remarks
Holding Value $2.49M 141,623 shares
Last Trade
Jun 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$17.59
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
See Remarks
Holding Value $9.47M 538,517 shares
Last Trade
Apr 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$17.59

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up